A randomized phase II study comparing induction or consolidation chemotherapy with cisplatin-docetaxel, plus radical concurrent chemoradiotherapy with cisplatin-docetaxel, in patients with unresectable locally advanced non-small-cell lung cancer


Senan S., Cardenal F., Vansteenkiste J., Stigt J., Akyol F., De Neve W., ...Daha Fazla

ANNALS OF ONCOLOGY, cilt.22, sa.3, ss.553-558, 2011 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 22 Konu: 3
  • Basım Tarihi: 2011
  • Doi Numarası: 10.1093/annonc/mdq388
  • Dergi Adı: ANNALS OF ONCOLOGY
  • Sayfa Sayıları: ss.553-558

Özet

Background: In stage III non-small-cell lung cancer (NSCLC), the role of systemic chemotherapy preceding or following concurrent chemo-radiotherapy (CT-RT) is unclear. We carried out a randomized phase II study to study the toxicity involved-field CT-RT with either induction or consolidation cisplatin-docetaxel (Taxotere).